{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:13:18Z","timestamp":1783548798097,"version":"3.55.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Both FGF-23 and PTH inhibit renal phosphate reabsorption. We treated two patients with TIO and FGF-23\u2013mediated hypophosphatemia with cinacalcet to test the hypothesis that medicinally induced hypoparathyroidism would decrease renal phosphate wasting. Cinacalcet treatment resulted in increased renal phosphate reabsorption, allowed for a decrease in phosphate supplementation, and showed evidence of bone healing in one of the two patients.<\/jats:p>\n               <jats:p>Introduction: Tumor-induced osteomalacia (TIO) is a rare, acquired disease of renal phosphate wasting, which results in hypophosphatemia and osteomalacia. It is caused by mesenchymal tumors that produce the phosphate and vitamin D\u2013regulating hormone, fibroblast growth factor (FGF)-23. Removal of the tumor is curative, but the tumors are often difficult to locate. Medical treatment involves high doses of oral phosphate and calcitriol, but the phosphate is often poorly tolerated and leads to diarrhea. Because PTH also promotes phosphaturia, and patients with hypoparathyroidism are hyperphosphatemic in the setting of elevated serum FGF-23, we postulated that the calcium-sensing receptor agonist, cinacalcet, which can induce hypoparathyroidism, would be an effective adjuvant in the treatment of TIO.<\/jats:p>\n               <jats:p>Materials and Methods: Two subjects with presumed TIO in whom the tumor was not located after extensive testing and who did not tolerate medical therapy with phosphorus and calcitriol were treated with cinacalcet.<\/jats:p>\n               <jats:p>Results: Neither treatment with phosphorus nor combined treatment with phosphorus and calcitriol had an effect on serum FGF-23 levels. Treatment with cinacalcet resulted in increased renal phosphate reabsorption and serum phosphorus and allowed for a decrease in phosphate supplementation to a dose that was tolerated. On this regimen, one patient showed significant bone healing as shown by resolution of activity on bone scan and lack of osteomalacia as assessed by histomorphometry.<\/jats:p>\n               <jats:p>Conclusions: These data show that medically induced hypoparathyroidism with cinacalcet is a therapeutic option for disorders of FGF-23\u2013mediated hypophosphatemia and that, in the absence of PTH, the phosphaturic effect of FGF-23 is decreased.<\/jats:p>","DOI":"10.1359\/jbmr.070304","type":"journal-article","created":{"date-parts":[[2007,3,12]],"date-time":"2007-03-12T13:40:04Z","timestamp":1173706804000},"page":"931-937","source":"Crossref","is-referenced-by-count":124,"title":["Cinacalcet in the Management of Tumor-Induced Osteomalacia"],"prefix":"10.1093","volume":"22","author":[{"given":"Jordan L","family":"Geller","sequence":"first","affiliation":[{"name":"Clinical Research Institute, Cedars-Sinai Medical Center and the David Geffen School of Medicine at UCLA, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azarmindokht","family":"Khosravi","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn H","family":"Kelly","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Riminucci","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Experimental Medicine, University of L'Aquila, L'Aquila, Italy"},{"name":"Dipartimento di Medicina Sperimentale e Patologia, Universita \u201cLa Sapienza,\u201d Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Adams","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Cedars-Sinai Medical Center and the David Geffen School of Medicine at UCLA, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Collins","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024020319301646300_bib1","doi-asserted-by":"crossref","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","article-title":"Phosphatonins and the regulation of phosphorus homeostasis","volume":"289","author":"Berndt","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"2024020319301646300_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"2024020319301646300_bib3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","article-title":"Bone as a source of FGF23: regulation by phosphate?","volume":"35","author":"Mirams","year":"2004","journal-title":"Bone"},{"key":"2024020319301646300_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"2024020319301646300_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2024020319301646300_bib6","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"2024020319301646300_bib7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM199406093302304","article-title":"Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia","volume":"330","author":"Cai","year":"1994","journal-title":"N Engl J Med"},{"key":"2024020319301646300_bib8","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"de Jan Beur","year":"2005","journal-title":"JAMA"},{"key":"2024020319301646300_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S8756-3282(00)00334-3","article-title":"Tumor-induced osteomalacia and the regulation of phosphate homeostasis","volume":"27","author":"Kumar","year":"2000","journal-title":"Bone"},{"key":"2024020319301646300_bib10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319301646300_bib11","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2004-0724","article-title":"FGF-23 is elevated by chronic hyperphosphatemia","volume":"89","author":"Gupta","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319301646300_bib12","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1359\/JBMR.050718","article-title":"Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D","volume":"20","author":"Collins","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2024020319301646300_bib13","first-page":"473","article-title":"NPS R-568: A type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium","volume":"290","author":"Fox","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"2024020319301646300_bib14","first-page":"2264","article-title":"Changes in quantitative bone histomorphometry in aging healthy men","volume":"81","author":"Clarke","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319301646300_bib15","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"2024020319301646300_bib16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI113172","article-title":"Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D","volume":"80","author":"Portale","year":"1987","journal-title":"J Clin Invest"},{"issue":"S1","key":"2024020319301646300_bib17","first-page":"S318","article-title":"FGF-23 and 1,25D in children with hypophposphatemic rickets: Effect of treatment with phosphate, cinacalcet and rocaltrol","volume":"21","author":"Levy-Olomucki","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024020319301646300_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.nutr.25.050304.092642","article-title":"Regulation of phosphorus homeostasis by the type iia na\/phosphate cotransporter","volume":"25","author":"Tenenhouse","year":"2005","journal-title":"Annu Rev Nutr"},{"key":"2024020319301646300_bib19","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"2024020319301646300_bib20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"2024020319301646300_bib21","doi-asserted-by":"crossref","first-page":"28265","DOI":"10.1074\/jbc.M202527200","article-title":"Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway","volume":"277","author":"Yamashita","year":"2002","journal-title":"J Biol Chem"},{"key":"2024020319301646300_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024020319301646300_bib23","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"2024020319301646300_bib24","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319301646300_bib25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024020319301646300_bib26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.070304","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/22\/6\/931\/56552965\/5650220618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/22\/6\/931\/56552965\/5650220618.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:48:36Z","timestamp":1710341316000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/22\/6\/931-937\/7597403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.070304","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,6,1]]},"published":{"date-parts":[[2007,6,1]]}}}